Guixiao Huang
-
- Nanoplatforms for cancer theranostics 2
-
- Cancer, Lipids, and Metabolism 2
-
- Bladder and Urothelial Cancer Treatments 5
-
- Ferroptosis and cancer prognosis 3
-
- Immune cells in cancer 3
-
- Pelvic floor disorders treatments 2
-
- Air Quality and Health Impacts 1
-
- Genetic Syndromes and Imprinting 1
- Partner nations
- China
In The Last Decade
Guixiao Huang
16 papers receiving 431 citations
Peers
Comparison fields: 5 of 71
- Biomaterials 87
- Biomedical Engineering 223
- Urology 22
- Pharmaceutical Science 20
- Cancer Research 39
Countries citing papers authored by Guixiao Huang
This map shows the geographic impact of Guixiao Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guixiao Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guixiao Huang more than expected).
Fields of papers citing papers by Guixiao Huang
This network shows the impact of papers produced by Guixiao Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guixiao Huang. The network helps show where Guixiao Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guixiao Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 15 | |
| 6 | 2024 | 13 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 47 | |
| 10 | 2023 | 0 | |
| 11 | 2022 | 12 | |
| 12 | 2021 | 12 | |
| 13 | 2021 | 13 | |
| 14 | 2021 | 11 | |
| 15 | 2020 | 11 | |
| 16 | 2020 | 81 | |
| 17 | 2020 | 203 | |
| 18 | 2019 | 5 |
About Guixiao Huang
Guixiao Huang is a scholar working on Cancer Research, Immunology and Surgery, having authored 18 papers that have together received 434 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Ferroptosis and cancer prognosis (3 papers), Immune cells in cancer (3 papers), Pelvic floor disorders treatments (2 papers), Cancer, Lipids, and Metabolism (2 papers), Nanoplatforms for cancer theranostics (2 papers), Air Quality and Health Impacts (1 paper) and Genetic Syndromes and Imprinting (1 paper). The work is most often cited by research in Biomaterials (87 citations), Biomedical Engineering (223 citations) and Urology (22 citations). Guixiao Huang has collaborated with scholars based in China. Frequent co-authors include Song Wu, Guangzhi Li, Zhuang Liu, Dashi Deng, Wen Zhong, Enpu Zhang, Qifang Lei, Zhiping Wang, Zhisheng Xiao and Ziliang Dong. Their work appears in journals such as ACS Nano, Frontiers in Microbiology and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.